$11.37M Hetero Valsartan Drug Contamination Settlement, Could You Qualify for a Cash Payment? Claim Before June 2, 2026
If you paid out of pocket for valsartan blood pressure medication made by Hetero between May 1 and July 31, 2018, you may be entitled to cash from an $11.37 million class action settlement. The lawsuit claims those pills contained NDMA — a probable cancer-causing chemical. Hetero denies wrongdoing but agreed to settle. The deadline…
